News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Barlow Carrolee
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/27/2023 |
4
| Barlow Carrolee (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 6,293 options to buy
@ $38.6, valued at
$242.9k
Granted 3,886 restricted stock units
@ $0 |
|
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Barlow Carrolee (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 7,365 options to buy
@ $29.61, valued at
$218.1k
Granted 4,222 restricted stock units
@ $0 |
|
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2019 |
4
| Barlow Carrolee (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC|
Txns:
| Granted 12,427 options to buy
@ $36.75, valued at
$456.7k
|
|
| 07/02/2018 |
4
| Barlow Carrolee (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC|
Txns:
| Granted 10,213 options to buy
@ $58.15, valued at
$593.9k
|
|
| 07/02/2018 |
3
| Barlow Carrolee (Director) has filed a Form 3 on SUPERNUS PHARMACEUTICALS INC |
|
|